You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Go to Close Top

Dosage and administration

 

  • Children aged 1 to 4 years: Optimal control of asthma is achieved with 100 µg twice daily, administered via a paediatric spacer device with a face mask
  • Children ≥ 4 years of age: 50 - 200 µg twice daily.

Flixotide is a trademark of GlaxoSmithKline group of companies.
To report an Adverse Event, please contact the toll free line 0800 CALL GSK (0800 2255 475) or send an
email.